Výsledky vyhledávání - "Helmut Sörensen"

Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years--early clinical response predicts long-term outcome

Autor: Juergen Braun, Joachim Listing, Joachim Sieper, Hildrun Haibel, Helmut Sörensen, Gerd-Rüdiger Burmester, R. Alten, Andreas Krause, Reinhold Schmidt, Stefan Schewe, Xenofon Baraliakos, Matthias Schneider, C. Fritz

Publikováno v: Rheumatology. 50:1690-1699

OBJECTIVES To report for the first time on the efficacy and safety of anti-TNF therapy after 8 years of follow-up in patients with active AS, and analyse possible short-term predictors for long-term clinical outcomes. METHODS In this open-label exten

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b433666d33319440795864dacaac27e
https://doi.org/10.1093/rheumatology/ker194

Zobrazit plný text záznamu

Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitis

Autor: Xenofon, Baraliakos, Joachim, Listing, Martin, Rudwaleit, Jan, Brandt, Rieke, Alten, Gerd, Burmester, Erika, Gromnica-Ihle, Hildrun, Haibel, Stephan, Schewe, Matthias, Schneider, Helmut, Sörensen, Henning, Zeidler, Sudha, Visvanathan, Joachim, Sieper, Juergen, Braun

Publikováno v: The Journal of rheumatology. 34(3)

To analyze the safety and efficacy of the anti-tumor necrosis factor agent infliximab in patients with ankylosing spondylitis (AS) after discontinuation of longterm therapy over 1 year and readministration, using clinical and laboratory assessments i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::377b7ffbd7391467f8f3621242f4004a
https://pubmed.ncbi.nlm.nih.gov/18785300

Zobrazit plný text záznamu

Muskulatur als bestes Medikament

Autor: Helmut Sörensen

Publikováno v: Orthopädie und Unfallchirurgie - Mitteilungen und Nachrichten. :528-528

Argumente fur mehr Bewegung sammelt auch der siebente Arthrosetag. Er fand mit etwa 300 Teilnehmern am 22. Oktober am Rande des Deutschen Kongresses fur Orthopadie und Unfallchirurgie in Berlin statt.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b8b7907c7ef8760ddfac103b660e585a
https://doi.org/10.1055/s-0041-108846

Zobrazit plný text záznamu

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

Autor: Xenofon, Baraliakos, Joachim, Listing, Jan, Brandt, Angela, Zink, Rieke, Alten, Gerd, Burmester, Erika, Gromnica-Ihle, Herbert, Kellner, Matthias, Schneider, Helmut, Sörensen, Henning, Zeidler, Martin, Rudwaleit, Joachim, Sieper, Juergen, Braun

Publikováno v: Arthritis Research & Therapy

We analyzed the clinical response and the time to relapse after discontinuation of continuous long-term infliximab therapy in patients with ankylosing spondylitis (AS). After 3 years of infliximab therapy, all AS patients (n = 42) discontinued treatm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::383c7eb38ad27b8abc34dd7a4ea323cb
https://pubmed.ncbi.nlm.nih.gov/15899063

Zobrazit plný text záznamu

Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept

Autor: Jan, Brandt, Andre, Khariouzov, Joachim, Listing, Hildrun, Haibel, Helmut, Sörensen, Martin, Rudwaleit, Joachim, Sieper, Jurgen, Braun

Publikováno v: The Journal of rheumatology. 31(3)

Anti-tumor necrosis factor-a (TNF-alpha) therapy has been successfully used in patients with active ankylosing spondylitis (AS) and other subtypes of spondyloarthritis (SpA). Treatment options for patients with severe forms of undifferentiated spondy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f105d1fb7d2c26f666a21782238e8b8a
https://pubmed.ncbi.nlm.nih.gov/14994401

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání